Professor Raph L Hamers
Developing collaborative clinical trials in Indonesia
Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.
- Associate Professor, Nuffield Dept of Medicine, University of Oxford
- Clinical Infectious Diseases Research Programme Leader, OUCRU Indonesia
- Manager of the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL)
- Internist and infectious disease physician
Oxford Clinical Research Unit Indonesia (EOCRU ID)
Raph Hamers, MD PhD, leads the clinical infectious disease research programme at the Oxford University Clinical Research Unit in Jakarta, Indonesia, and is an Associate Professor at Nuffield Department of Medicine, University of Oxford. He is also an honorary consultant internist and infectious disease physician at the Amsterdam University Medical Centres and an honorary research fellow at the Faculty of Medicine University of Indonesia (FKUI).
He earned a PhD in Medicine from the University of Amsterdam, and is a recipient of a Veni postdoc fellowship through the Dutch Research Council (NWO) Talent Programme. His research work spans from biomedicine to global health, with a focus on improving health outcomes of complex infectious diseases in low and middle income countries.
In 2018, Dr. Hamers established OUCRU Indonesia's clinical infectious disease research programme, embedded in the Universities of Indonesia-Oxford Clinical Research Laboratory (IOCRL) on the FKUI premises in Jakarta,. IOCRL is a facility that serves as a clinical trials unit and hub for research training and public and community engagement with science in Indonesia. His work emphasizes strengthening local research capacity and developing a broader collaborative clinical research agenda in Indonesia, with OUCRU's principal partners and the Oxford Tropical Network.
Dr. Hamers has extensive experience as a lead investigator of clinical trials and connected epidemiological, social and laboratory science in sub-Saharan Africa and Southeast Asia, with a focus on the diagnosis and clinical management, drug resistance and immune function in HIV-1 infection, the clinical management of tuberculosis, antimicrobial stewardship interventions, and emerging infectious diseases. His research portfolio since 2020 also covers COVID-19 including diagnostics, assessment of vaccines and therapeutics, and impacts on the wider health system in Indonesia.
Inzaule SC. et al, (2022), AIDS (London, England), 36, 1437 - 1447
Suwarti S. et al, (2022), The American journal of tropical medicine and hygiene
Limato R. et al, (2022), Antimicrobial resistance and infection control, 11
Myint KSA. et al, (2022), The American journal of tropical medicine and hygiene
Hamers RL. et al, (2022), BMJ open, 12
Surendra H. et al, (2022), BMJ Glob Health, 7
Sinto R. et al, (2022), Antimicrobial resistance and infection control, 11
Limato R. et al, (2022), BMJ open, 12
Limato R. et al, (2022)
Abani O. et al, (2022), The Lancet, 399, 665 - 676